170 related articles for article (PubMed ID: 23363786)
1. The high rate of de novo graft carcinomas in renal transplant recipients.
Viart L; Surga N; Collon S; Jaureguy M; Elalouf V; Tillou X
Am J Nephrol; 2013; 37(2):91-6. PubMed ID: 23363786
[TBL] [Abstract][Full Text] [Related]
2. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
3. Contralateral nephroureterectomy for renal transplant recipients with unilateral upper urinary tract transitional cell carcinoma: a report of 12 cases.
Hou HJ; Xiao J; Tian Y
Transplant Proc; 2013; 45(6):2203-6. PubMed ID: 23850405
[TBL] [Abstract][Full Text] [Related]
4. De novo renal carcinoma in renal transplant recipients: effect of early treatment.
Tillou X; Demailly M; Hakami F; Westeel PF; Saint F; Petit J
Transplant Proc; 2009 Oct; 41(8):3314-6. PubMed ID: 19857739
[TBL] [Abstract][Full Text] [Related]
5. Regular ultrasound examination of transplanted kidneys allows early diagnosis of renal cell carcinoma and conservative nephron sparing surgery.
Lentini P; Granata A; Ciancio A; Gallieni M
Arch Ital Urol Androl; 2011 Dec; 83(4):195-9. PubMed ID: 22670317
[TBL] [Abstract][Full Text] [Related]
6. [De novo urologic tumors in kidney transplant patients].
Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
[TBL] [Abstract][Full Text] [Related]
7. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
8. Updated National Study of Functional Graft Renal Cell Carcinomas: Are They a Different Entity?
Szabla N; Matillon X; Calves J; Branchereau J; Champy C; Neuzillet Y; Bessede T; Bouhié S; Boutin JM; Caillet K; Cognard N; Culty T; De Fortescu G; Drouin S; Bentellis I; Hubert J; Boissier R; Sallusto F; Sénéchal C; Terrier N; Thuret R; Verhoest G; Waeckel T; Tillou X
Urology; 2023 Jan; 171():152-157. PubMed ID: 36243142
[TBL] [Abstract][Full Text] [Related]
9. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
10. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
[TBL] [Abstract][Full Text] [Related]
11. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis and treatment of renal cell carcinoma of native kidney in kidney transplantation.
García Álvarez T; Mazuecos Blanca A; Navas García N; Calle García L; Vallejos Roca E; Moreno Salazar A; Soto Villalba J; Collantes Mateos R; Rivero Sánchez M
Nefrologia; 2011; 31(5):567-72. PubMed ID: 21959723
[TBL] [Abstract][Full Text] [Related]
13. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
Holmäng S; Johansson SL
Cancer; 2004 Aug; 101(4):741-7. PubMed ID: 15305404
[TBL] [Abstract][Full Text] [Related]
14. De novo kidney graft tumors: results from a multicentric retrospective national study.
Tillou X; Doerfler A; Collon S; Kleinclauss F; Patard JJ; Badet L; Barrou B; Audet M; Bensadoun H; Berthoux E; Bigot P; Boutin JM; Bouzguenda Y; Chambade D; Codas R; Dantal J; Deturmeny J; Devonec M; Dugardin F; Ferrière JM; Erauso A; Feuillu B; Gigante M; Guy L; Karam G; Lebret T; Neuzillet Y; Legendre C; Perez T; Rerolle JP; Salomon L; Sallusto F; Sénéchal C; Terrier N; Thuret R; Verhoest G; Petit J;
Am J Transplant; 2012 Dec; 12(12):3308-15. PubMed ID: 22959020
[TBL] [Abstract][Full Text] [Related]
15. Kidney Graft Urothelial Carcinoma: Results From a Multicentric Retrospective National Study.
Leon G; Szabla N; Boissier R; Gigante M; Caillet K; Verhoest G; Tillou X;
Urology; 2020 Jan; 135():101-105. PubMed ID: 31560916
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes in Renal Transplant Recipients With Renal Cell Carcinoma or Transitional Cell Carcinoma From the ANZDATA Database.
Ranasinghe WK; Suh N; Hughes PD
Exp Clin Transplant; 2016 Apr; 14(2):166-71. PubMed ID: 26669303
[TBL] [Abstract][Full Text] [Related]
17. De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: a case report.
Numakura K; Satoh S; Tsuchiya N; Saito M; Nara T; Huang M; Tsuruta H; Akihama S; Inoue T; Narita S; Habuchi T
Prog Transplant; 2014 Dec; 24(4):328-31. PubMed ID: 25488554
[TBL] [Abstract][Full Text] [Related]
18. Urological tumors in renal transplantation.
Tillou X; Doerfler A
Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in functional renal graft: Toward ablative treatments.
Tillou X; Guleryuz K; Collon S; Doerfler A
Transplant Rev (Orlando); 2016 Jan; 30(1):20-6. PubMed ID: 26318289
[TBL] [Abstract][Full Text] [Related]
20. De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients.
Tsaur I; Obermüller N; Jonas D; Blaheta R; Juengel E; Scheuermann EH; Kachel HG; Karalis A; Probst M
BJU Int; 2011 Jul; 108(2):229-34. PubMed ID: 21070582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
